Compare WVE & KWR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | WVE | KWR |
|---|---|---|
| Founded | 2012 | 1918 |
| Country | Singapore | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.4B | 2.3B |
| IPO Year | 2015 | 1994 |
| Metric | WVE | KWR |
|---|---|---|
| Price | $6.19 | $143.04 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 16 | 3 |
| Target Price | $29.81 | ★ $167.00 |
| AVG Volume (30 Days) | ★ 3.9M | 118.5K |
| Earning Date | 04-28-2026 | 04-30-2026 |
| Dividend Yield | N/A | ★ 1.52% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.13 |
| Revenue | $3,704,000.00 | ★ $1,888,634,000.00 |
| Revenue This Year | N/A | $5.16 |
| Revenue Next Year | $85.67 | $3.63 |
| P/E Ratio | ★ N/A | $126.59 |
| Revenue Growth | ★ 149.43 | 2.66 |
| 52 Week Low | $5.02 | $104.13 |
| 52 Week High | $21.73 | $183.01 |
| Indicator | WVE | KWR |
|---|---|---|
| Relative Strength Index (RSI) | 35.45 | 54.41 |
| Support Level | $6.02 | $128.74 |
| Resistance Level | $7.65 | $145.92 |
| Average True Range (ATR) | 0.35 | 5.27 |
| MACD | 0.05 | 0.14 |
| Stochastic Oscillator | 15.04 | 65.13 |
WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.
Quaker Houghton manufactures and sells a variety of industrial process fluids. The company's product portfolio includes metal removal fluids, cleaning fluids, corrosion inhibitors, metal drawing and forming fluids, die-cast mold releases, heat treatment and quenchants, metal forging fluids, hydraulic fluids, specialty greases, offshore sub-sea energy control fluids, rolling lubricants, rod and wire drawing fluids, and surface treatment chemicals. The company's geographic segments include the Americas, EMEA, and Asia/Pacific. The majority of the company's revenue is earned from the Americas.